Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

While the early-stage results would need to be validated in larger studies, the researchers said the findings offer hope for ...

A new study reveals that simply seeing a visibly “infectious” figure can set off a chain reaction in the brain’s ...

Phase 1 study results published in Nature Medicine looks at a vaccine for patients with pancreatic and colorectal cancer. Dr Magnus Dillon, Clinician Scientist at The Institute of Cancer Research, ...

Additionally, a baseline immune response to GP2 was observed before any treatment with GP2 in both HLA-A*02 and non-HLA-A*02 arms. These two immune responses were also observed in the Phase 2b ...

Treatment with the investigative agent GLSI-100 (GP2 plus GM-CSF) demonstrated an increased immune response over time in patients with HER2-positive breast cancer following surgery, according to ...